In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-60224-3
Affiliations:
11
Authors:
15
Institutions Authors Share
Toulouse Institute For Infectious and Inflammatory Diseases, France
6.833333
0.46
Oswaldo Cruz Foundation (FIOCRUZ), Brazil
3.500000
0.23
National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Brazil
1.166667
0.08
University of São Paulo (USP), Brazil
1.000000
0.07
Hospital Israelita Albert Einstein, Brazil
1.000000
0.07
Toulouse University Hospital (CHU-Toulouse), France
1.000000
0.07
Medical University of Vienna (MUW), Austria
0.500000
0.03